Cardiac hormones eliminate some human squamous lung carcinomas in athymic mice

European Journal of Clinical Investigation

Volumn 40, Issue 3, 2010, Pages 242-249

  Lenz, A ^a   Sun, Y ^a   Eichelbaum, E J ^a   Skelton IV, W P ^a   Pi, G ^a   Vesely, D L ^a,b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Metastasis; Natriuretic peptides; New therapeutics; Squamous cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; ATRIAL NATRIURETIC FACTOR; KALIURETIC PEPTIDE; LONG ACTING NATRIURETIC FACTOR; UNCLASSIFIED DRUG; VESSEL DILATOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DIARRHEA; HYPOTENSION; LUNG SQUAMOUS CELL CARCINOMA; MALE; MOUSE; NAUSEA; NONHUMAN; PAIN; PRIORITY JOURNAL; SEIZURE; TUMOR LOCALIZATION; TUMOR VOLUME;

ANIMALS; ANTINEOPLASTIC AGENTS; ATRIAL NATRIURETIC FACTOR; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM METASTASIS; PEPTIDE FRAGMENTS; TUMOR CELLS, CULTURED;

EID: 77649204058     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02262.x     Document Type: Article

References (25)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer Statistics 2009. CA Cancer J Clin 2009 59 : 225 249.
2. Onn A, Vaporciyan AA, Chang JY, Komaki R, Roth JA, Herbst RS. Cancer of the Lung. In : Kufe DW, Bast RC Jr., Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E III., editors. Cancer Medicine 7. London : BC Decker, Inc 2006 7 : 1179 1224.
3. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML. Diverse biological action of atrial natriuretic peptide. Physiol Rev 1990 70 : 665 699.
4. Vesely DL. Natriuretic peptides and acute renal failure. Am J Physiol 2003 285 : F167 77.
5. Vesely DL. Natriuretic hormones. In: Seldin and Giebisch's The Kidney: Physiology and Pathophysiology, 4th edn. Alpern RJ, Herbert SC, editors. Amsterdam, The Netherlands : Elsevier Inc. 2007 : pp. 947 977.
6. Eichelbaum EJ, Sun Y, Alli AA, Gower WR Jr., Vesely DL. Cardiac hormones and urodilatin eliminate up to 86% of human small-cell lung carcinomas in mice. Eur J Clin Invest 2008 38 : 562 570.
7. Vesely BA, Fitz SR, Gower WR Jr., Vesely DL. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of squamous lung cancer cells. Cancer Lett 2006 232 : 226 231.
8. Duguay D, Mercier F, Stagg J, Martineau D, Bramson J, Servant M et al. In vivo interferon regulatory factor 3-tumor suppressor activity in B16 melanoma tumors. Cancer Res 2002 62 : 5148 5152.
9. Vesely BA, Alii AA, Song S, Gower SR Jr., Sanchez-Ramoa J, Vesely DL. Four peptide hormones specific decrease (up to 97%) of human prostrate carcinoma cells. Eur J Clin Invest 2005 35 : 700 710. (Pubitemid 41640906)
10. Gower WR Jr., Vesely BA, Alii AA, Vesely DL. Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via guanosine 3′5′-cyclic monophosphate. Int J Gastrointest Cancer 2005 36 : 77 88.
11. Vesely DL, Eichelbaum EJ, Sun Y, Alli AA, Vesely BA, Luther SI et al. Elimination of up to 80% of human pancreatic adenocarcinomas in athymic mice by cardiac hormones. In Vivo 2007 21 : 445 452. (Pubitemid 46901402)
12. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Vessel dilator and kaliuretic peptide inhibit activation of ERK 1/2 in human prostate cancer cells. Anticancer Res 2006 26 : 3217 3222. (Pubitemid 44701488)
13. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Atrial natriuretic peptide and long acting natriuretic peptide inhibit ERK 1/2 in prostate cancer cells. Anticancer Res 2006 26 : 4143 4148. (Pubitemid 46031483)
14. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Vessel dilator and kaliuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 2007 27 : 1387 1392.
15. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Atrial natriuretic peptide and long acting natriuretic peptide inhibit MEK 1/2 activation in human prostate cancer cells. Anticancer Res 2007 27 : 3813 3818.
16. Sun Y, Eichelbaum EJ, Lenz A, Skelton WP IV., Wang Y, Vesely DL. Atrial natriuretpc peptide and long acting natriuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 2009 29 : 1889 1893.
17. Sun Y, Eichelbaum EJ, Skelton WP IV., Lenz A, Regales N, Wang H et al. Vessel dilator and kaliuretic peptide inhibit Ras in human prostate cancer cells. Anticancer Res 2009 29 : 971 976.
18. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EWT, Chang F et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation, and drug resistance. Biochim Biophys Acta 2007 1773 : 1263 1284.
19. Sebolt-Leopold JS, Herrera R. Targeting the mitogen-activated protein kinase cascard to treat cancer. Nat Rev Cancer 2004 4 : 937 947.
20. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Insulin and epidermal growth factor activation of ERK 1/2 and DNA synthesis is inhibited by four cardiac hormones. J Cancer Mol 2007 3 : 113 120.
21. Sun Y, Eichelbaum EJ, Lenz A, Wang H, Vesely DL. Four cardiac hormones inhibit insulin's mitogenic action via inhibiting Ras. Cancer Ther 2009 7 : 367 372.
22. Sun Y, Eichelbaum EJ, Wang H, Vesely DL. Vessel dilator and kaliuretic peptide activate ERK 1/2 kinases in fibroblasts. Horm Metab Res 2009 41 : 197 201.
23. Vesely DL. Atrial natriuretic hormones originating from the N-terminus of the atrial natriuretic factor prohormone. Clin Exp Pharmacol Physiol 1995 22 : 108 114.
24. Daggubati S, Parks JR, Overton RM, Cintron G, Schocken DD, Vesely DL. Adrenomedullin, endothelin, neuropeptide Y, atrial, brain, and C-natriuretic prohormone peptides compared as early heart failure indicators. Cardiovasc Res 1997 36 : 246 255.
25. Franz M, Woloszczuk W, Horl WH. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases. Kidney Int 2001 59 : 1928 1934.